{
  "id": 11957407,
  "title": "Nigeria: Nigerian Drugmaker Fidson Selected to Manufacture Generic Influenza Antiviral Under Global Licence",
  "url": "https://urgent.news/2026/10/04/nigeria-nigerian-drugmaker-fidson-selected-to-manufacture-generic",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-04T15:57:06.000Z",
  "source": {
    "name": "AllAfrica Health",
    "slug": "allafrica-health",
    "url": "https://allafrica.com/stories/202610040065.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Nigerian pharmaceutical company Fidson Healthcare Plc has been selected to manufacture a generic version of baloxavir marboxil, an antiviral medicine used to treat influenza. This selection makes Fidson one of 11 manufacturers across nine countries chosen under a voluntary licensing agreement between the Medicines Patent Pool (MPP) and Swiss pharmaceutical company Roche. The MPP, a United Nations-backed public health organisation, selected manufacturers from Brazil, China, India, Indonesia, Malaysia, Nigeria, Uganda, Ukraine, and Vietnam to diversify supply pathways for influenza treatment, support regional production, and strengthen preparedness for future outbreaks and pandemics.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "AllAfrica",
        "title": "Nigeria: Nigerian Drugmaker Fidson Selected to Manufacture Generic Influenza Antiviral Under Global Licence",
        "url": "https://urgent.news/2026/10/04/nigeria-nigerian-drugmaker-fidson-selected-to-manufacture-generic-11960383",
        "published": "2026-10-04T15:57:06.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}